Physical Properties
Recommended Separation Techniques
Ranked by effectiveness for recombinant insulin purification from E. coli inclusion bodies or S. cerevisiae secretion.
The gold standard for insulin polishing. C8 or C18 columns with acetonitrile/water gradients (0.1% TFA) resolve insulin from desamido variants, proinsulin, and scrambled disulfide isomers with baseline separation. At 5,808 Da, insulin has excellent RP-HPLC behavior. Required for pharmaceutical-grade purity (>98%). Typical loading: 5–20 g/L resin.
Cation exchange (SP, CM resins) at pH 4.0–5.0 captures insulin (positively charged below pI 5.3) while allowing acidic impurities to flow through. Alternatively, anion exchange at pH 7–8 binds insulin weakly (charge -2). IEX is the primary capture step after refolding, removing >90% of host cell proteins.
SEC on Superdex 75 separates insulin monomer/dimer (5.8–11.6 kDa) from high-MW aggregates and low-MW impurities (C-peptide fragments, salts). Also serves as an analytical method for aggregate quantification. Limited scalability; best as an intermediate or polishing step.
Insulin crystallizes as zinc-coordinated hexamers at pH 5.5–6.5 with 0.5–2 mg/mL Zn²+. Rhombohedral crystals exclude many impurities. Used both as a purification step and for formulation (crystalline insulin suspensions for sustained release). Crystallization yield: 70–85%.
Common Impurity Separations
| Separate From | Key Difference | Best Technique | Selectivity Basis |
|---|---|---|---|
| Proinsulin | MW (5.8 vs 9.4 kDa), hydrophobicity | RP-HPLC | Hydrophobic surface area difference |
| E. coli HCP | Size, charge, hydrophobicity | IEX + RP-HPLC (multi-step) | Orthogonal selectivities |
| Endotoxins (LPS) | Size (5.8 kDa vs >10 kDa aggregates), charge | Anion Exchange + UF | LPS strongly negative; insulin weakly charged |
| Insulin Aggregates | Size (monomer vs oligomers/fibrils) | SEC / UF (30 kDa MWCO) | Molecular weight difference |
Disulfide Bond Folding & Refolding
Correct disulfide pairing is critical for insulin activity and a major purification challenge.
Disulfide Architecture
Insulin has three disulfide bonds: A7–B7 (inter-chain), A20–B19 (inter-chain), and A6–A11 (intra-chain A). From 6 cysteines, 15 possible pairings exist, but only one is biologically active. Misfolded “scrambled” isomers must be separated.
Refolding & Purification Strategy (E. coli route)
| Step | Operation | Purpose |
|---|---|---|
| 1 | Cell lysis + IB recovery | Isolate inclusion bodies (centrifugation) |
| 2 | Solubilization (8 M urea + DTT) | Denature & reduce all disulfides |
| 3 | Refolding (dilution, oxidized/reduced glutathione) | Form correct disulfides; 30–60% yield |
| 4 | Cation exchange capture | Remove misfolded variants & HCP |
| 5 | RP-HPLC polishing | Resolve insulin from desamido & scrambled forms |
| 6 | Zinc crystallization | Final purification & formulation |
Frequently Asked Questions
What is the typical downstream process for recombinant insulin?
For E. coli inclusion body expression: cell disruption, IB wash, solubilization in urea/DTT, refolding with controlled oxidation, enzymatic cleavage (trypsin + carboxypeptidase B for proinsulin route), cation exchange capture, RP-HPLC polishing, and zinc crystallization. Total yield: 15–30% from fermentation. Design your route with untangle.bio.
Why is RP-HPLC essential for insulin purification?
RP-HPLC is the only technique that reliably resolves insulin from closely related variants: desamido-insulin (Asn→Asp, +1 Da), proinsulin (C-peptide still attached), and scrambled disulfide isomers (same MW, different fold). These variants have near-identical charge and size but differ in surface hydrophobicity.
How does insulin crystallization work?
Insulin forms zinc-coordinated hexamers (2 Zn²+ per hexamer) that pack into rhombohedral crystals at pH 5.5–6.5. Crystallization conditions: 5–20 mg/mL insulin, 0.5–2 mg/mL ZnCl₂, acetate buffer pH 5.5–6.0, slow cooling or vapor diffusion. Phenol or m-cresol can shift the crystal form (T₆, T₃R₃, R₆).
What are the key impurities in recombinant insulin?
Host cell proteins (HCP, <10 ppm required), endotoxins (<5 EU/dose), proinsulin (<10 ppm), desamido-insulin (<1%), scrambled disulfide isomers, aggregates (<1%), and residual DNA (<10 pg/dose). Pharmacopoeial specifications (USP, EP) define limits for each. Multi-step purification with orthogonal selectivities is required.
Related Molecules
Design Your Insulin Purification Process
Build and simulate complete downstream processing routes with real mass balance and cost estimation.
Open untangle.bio